Hyderabad, Oct. 7 -- : Shanchol(R), the oral cholera vaccine originally developed by Hyderabad-based Shantha Biotechnics, has received prequalification from the World Health Organization (WHO). Shantha Biotechnics, founded in the 1990s, was acquired by Sanofi in 2009, gaining global recognition as a trusted vaccine supplier. In 2024, Shantha's facilities including Shanchol(R),were acquired by GCBC Vaccines Pvt. Ltd.
This milestone enables global procurement agencies such as UNICEF, Gavi, and PAHO to source Shanchol(R) for use in countries, where cholera remains a major public health challenge, the Biotech firm said in a release here on Tuesday.
"Shanchol was conceived as an affordable, accessible solution for countries facing repeated cho...